Peripheral blood circulating immature cell counts predict CD34+ cell yields in G‐CSF‐induced PBPC mobilization in healthy donors
Authors:
- Teruhiko KozukaTKTeruhiko Kozuka
- Kazuma IkedaKIKazuma Ikeda
- Takanori TeshimaTTTakanori Teshima
- Chikamasa YoshidaCYChikamasa Yoshida
- Katsuji ShinagawaKSKatsuji Shinagawa
- Kensuke KojimaKKKensuke Kojima
- Keitaro MatsuoKeitaro Matsuo
- Akihiro BesshoABAkihiro Bessho
- Kazutaka SunamiKSKazutaka Sunami
- Yasushi HiramatsuYHYasushi Hiramatsu
- Yoshinobu MaedaYMYoshinobu Maeda
- Toshio NoguchiTNToshio Noguchi
- 24 March 2004
- journal article
- clinical trial
- Published by Wiley in Transfusion
- Vol. 44 (4) , 526-532
Abstract
BACKGROUND: It has been previously reported that the number of circulating immature cells (CIC) in peripheral blood (PB) estimates the number of CD34+ cells collected in G‐CSF plus chemotherapy‐induced PBPC mobilization. The correlation of CIC counts in PB with CD34+ cell yield and its usefulness was evaluated in G‐CSF‐induced PBPC mobilization for healthy donors.STUDY DESIGN AND METHODS: CIC counts in PB and CD34+ cell counts in the apheresis product from 122 collections were assessed, and the relationship between these two variables was evaluated with the Pearson rank correlation analysis, the chi‐squared test, and the U‐test.RESULTS: CIC counts were correlated weakly with the number of CD34+ cells per L of blood processed in the apheresis product (Pearson rank correlation analysis; r = 0.357, p < 0.0001). When a level of 1.7 × 109 CICs per L was selected as a cutoff value, the sensitivity and specificity for collecting more than 20 × 106 CD34+ cells per L of blood processed were 63.6 and 77.5 percent, respectively.CONCLUSION: The present study suggests that the number of CICs in PB may estimate the number of CD34+ cells collected. The data indicate that CIC counts above 1.7 × 109 per L can be used as a good predictor for PBPC collections containing more than 20 × 106 CD34+ cells per L of blood processed in a single apheresis procedure.Keywords
This publication has 18 references indexed in Scilit:
- Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilizationBone Marrow Transplantation, 2003
- Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G–CSF plus chemotherapy‐induced mobilizationTransfusion, 2002
- Analysis of factors associated with low peripheral blood progenitor cell collection in normal donorsTransfusion, 2002
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collectionBone Marrow Transplantation, 2000
- Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trialThe Lancet, 2000
- Allogeneic peripheral blood stem cell transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD riskBone Marrow Transplantation, 1997
- Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cellsTransfusion, 1996
- Clinical toxicity and laboratory effects of granulocyte‐colony‐ stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the proceduresTransfusion, 1996
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996